tiprankstipranks
Development Technologies (DVTC)
OTHER OTC:DVTC
US Market

Development Technologies (DVTC) Price & Analysis

9 Followers

DVTC Stock Chart & Stats

$5.00
$0.00(0.00%)
At close: 4:00 PM EDT
$5.00
$0.00(0.00%)

DVTC FAQ

What was Development Technologies’s price range in the past 12 months?
Development Technologies lowest stock price was $5.00 and its highest was $5.00 in the past 12 months.
    What is Development Technologies’s market cap?
    Development Technologies’s market cap is $272.50M.
      When is Development Technologies’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Development Technologies’s earnings last quarter?
      Currently, no data Available
      Is Development Technologies overvalued?
      According to Wall Street analysts Development Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Development Technologies pay dividends?
        Development Technologies does not currently pay dividends.
        What is Development Technologies’s EPS estimate?
        Development Technologies’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Development Technologies have?
        Development Technologies has 54,500,996 shares outstanding.
          What happened to Development Technologies’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Development Technologies?
          Currently, no hedge funds are holding shares in DVTC
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Development Technologies

            Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.
            Similar Stocks
            Company
            Price & Change
            Follow
            SilverBox Corp IV Class A
            Cantor Equity Partners I, Inc. Class A
            Jackson Acquisition Co. II Class A
            Artius II Acquisition Inc. Class A
            Soulpower Acquisition Corp. Class A
            Popular Stocks